These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31323143)

  • 41. Differential constitutive activation between STAT-related proteins and MAP kinase in primary acute myelogenous leukaemia.
    Hayakawa F; Towatari M; Iida H; Wakao H; Kiyoi H; Naoe T; Saito H
    Br J Haematol; 1998 Jun; 101(3):521-8. PubMed ID: 9633897
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A preliminary immunohistochemical study of signal transducer and activator of transcription (STAT) proteins in primary oral malignant melanoma.
    Nikitakis NG; Gkouveris I; Papadopoulou E; Daskalopoulos A; Sklavounou A
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Feb; 125(2):164-171. PubMed ID: 29249519
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Repression of STAT3, STAT5A, and STAT5B expressions in chronic myelogenous leukemia cell line K-562 with unmodified or chemically modified siRNAs and induction of apoptosis.
    Kaymaz BT; Selvi N; Gündüz C; Aktan C; Dalmızrak A; Saydam G; Kosova B
    Ann Hematol; 2013 Jan; 92(2):151-62. PubMed ID: 23053176
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Signal transduction pathways induced by GM-CSF in microglia: significance in the control of proliferation.
    Liva SM; Kahn MA; Dopp JM; de Vellis J
    Glia; 1999 Jun; 26(4):344-52. PubMed ID: 10383053
    [TBL] [Abstract][Full Text] [Related]  

  • 45. DARPP32, STAT5 and STAT3 mRNA expression ratios in glioblastomas are associated with patient outcome.
    Televantou D; Karkavelas G; Hytiroglou P; Lampaki S; Iliadis G; Selviaridis P; Polyzoidis KS; Fountzilas G; Kotoula V
    Pathol Oncol Res; 2013 Apr; 19(2):329-43. PubMed ID: 23250732
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential patterns of placental and epithelial cadherin expression in basal cell carcinoma and in the epidermis overlying tumours.
    Pizarro A; Gamallo C; Benito N; Palacios J; Quintanilla M; Cano A; Contreras F
    Br J Cancer; 1995 Aug; 72(2):327-32. PubMed ID: 7640213
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunoexpression of p53 and COX-2 in basal cell carcinoma.
    Enache AO; Stepan AE; Mărgăritescu C; Pătraşcu V; Ciurea RN; Simionescu CE; Camen A
    Rom J Morphol Embryol; 2018; 59(4):1115-1120. PubMed ID: 30845292
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunohistochemical nuclear staining for p53, PCNA, and Ki-67 in different histologic variants of basal cell carcinoma.
    Barrett TL; Smith KJ; Hodge JJ; Butler R; Hall FW; Skelton HG
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):430-7. PubMed ID: 9308559
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The expression of p63 in basal cell carcinomas and association with histological differentiation.
    Bircan S; Candir O; Kapucoglu N; Baspinar S
    J Cutan Pathol; 2006 Apr; 33(4):293-8. PubMed ID: 16630179
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serine phosphorylation of Stat5 proteins in lymphocytes stimulated with IL-2.
    Xue HH; Fink DW; Zhang X; Qin J; Turck CW; Leonard WJ
    Int Immunol; 2002 Nov; 14(11):1263-71. PubMed ID: 12407017
    [TBL] [Abstract][Full Text] [Related]  

  • 51. VEGF, VEGFRs expressions and activated STATs in ovarian epithelial carcinoma.
    Chen H; Ye D; Xie X; Chen B; Lu W
    Gynecol Oncol; 2004 Sep; 94(3):630-5. PubMed ID: 15350351
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The genes induced by signal transducer and activators of transcription (STAT)3 and STAT5 in mammary epithelial cells define the roles of these STATs in mammary development.
    Clarkson RW; Boland MP; Kritikou EA; Lee JM; Freeman TC; Tiffen PG; Watson CJ
    Mol Endocrinol; 2006 Mar; 20(3):675-85. PubMed ID: 16293640
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Discordant expression of desmoglein 2 and 3 at the mRNA and protein levels in nodular and superficial basal cell carcinoma revealed by immunohistochemistry and fluorescent in situ hybridization.
    Pietkiewicz P; Gornowicz-Porowska J; Bowszyc-Dmochowska M; Jagielska J; Helak-Łapaj C; Kaczmarek E; Dmochowski M
    Clin Exp Dermatol; 2014 Jul; 39(5):628-35. PubMed ID: 24934917
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of beta-catenin in basal cell carcinoma.
    El-Bahrawy M; El-Masry N; Alison M; Poulsom R; Fallowfield M
    Br J Dermatol; 2003 May; 148(5):964-70. PubMed ID: 12786827
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue.
    Liu X; Robinson GW; Gouilleux F; Groner B; Hennighausen L
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8831-5. PubMed ID: 7568026
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Superficial, nodular, and morpheiform basal-cell carcinomas exhibit distinct gene expression profiles.
    Yu M; Zloty D; Cowan B; Shapiro J; Haegert A; Bell RH; Warshawski L; Carr N; McElwee KJ
    J Invest Dermatol; 2008 Jul; 128(7):1797-805. PubMed ID: 18200053
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Actin expression in purely nodular versus nodular-infiltrative basal cell carcinoma.
    Law AM; Oliveri CV; Pacheco-Quinto X; Horenstein MG
    J Cutan Pathol; 2003 Apr; 30(4):232-6. PubMed ID: 12680952
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of epidermal stem cell markers in skin and adnexal malignancies.
    Quist SR; Eckardt M; Kriesche A; Gollnick HP
    Br J Dermatol; 2016 Sep; 175(3):520-30. PubMed ID: 26914519
    [TBL] [Abstract][Full Text] [Related]  

  • 59. STAT3 polymorphisms and IL-6 polymorphism are associated with the risk of basal cell carcinoma in patients from northern Poland.
    Sławińska M; Zabłotna M; Gleń J; Lakomy J; Nowicki RJ; Sobjanek M
    Arch Dermatol Res; 2019 Nov; 311(9):697-704. PubMed ID: 31342143
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recurrent NMYC copy number gain and high protein expression in basal cell carcinoma.
    Freier K; Flechtenmacher C; Devens F; Hartschuh W; Hofele C; Lichter P; Joos S
    Oncol Rep; 2006 May; 15(5):1141-5. PubMed ID: 16596176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.